Physician profile
Nancy J Houchens
NPI 1740472414
$2,418.98
in general payments reported to CMS, 2019-2025
23 companies · $513 in 2025
The $513 reported for 2025 was more than what 77% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $635 · 2022: $521 · 2023: $483 · 2024: $266 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,198 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,197.81 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $647.96 | 2021-2025 | Lifevest |
| Pfizer INC. | $309.20 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $280.60 | 2021-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $207.69 | 2021-2025 | Verquvo, Capvaxive |
| Astrazeneca Pharmaceuticals LP | $193.83 | 2021-2023 | Atacand, Brilinta |
| Amgen INC. | $169.89 | 2021-2023 | Repatha |
| Abbott Laboratories | $95.86 | 2021-2023 | Cardiomems |
| Biotronik INC. | $88.09 | 2021-2023 | Recross |
| Novartis Pharmaceuticals Corporation | $68.78 | 2022-2025 | |
| Medtronic, INC. | $56.92 | 2022-2025 | Tyrx, Micra |
| Boston Scientific Corporation | $53.33 | 2022-2024 | Bodyguardian |
| Amarin Pharma, INC. | $43.32 | 2021 | |
| Vital Connect, INC | $29.94 | 2023 | Vitalpatch Rtm |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.08 | 2021-2022 | |
| Abbvie INC. | $19.91 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $19.71 | 2025 | Fanapt |
| Travere Therapeutics, INC. | $18.38 | 2023 | |
| Philips North America LLC | $16.94 | 2024 | (Ck4) Mcot |
| Cvrx, INC. | $16.75 | 2023 | Barostim Neo System |
| Astellas Pharma US INC | $15.97 | 2021 | |
| Lundbeck LLC | $13.69 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.65 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $12.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Houchens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.